Recent reports have stated that the administration of GLP-1 RA shows anti-inflammatory effects in low-grade inflammatory conditions such as atherosclerosis and non-alcoholic fatty liver disease [164,165]. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.